Dubai hosted a scientific occasion organised by the American Academy of Pediatrics, in collaboration with the Emirates Pediatrics and Neonatal Society, bringing collectively worldwide consultants and physicians from the UAE and the area to focus on the newest developments in influenza vaccination.
Dr. Entesar Al Hammadi, President of the Emirates Pediatrics and Neonatal Society, mentioned the newly launched influenza vaccine stands out for its nasal spray supply, changing conventional needle injections. This innovation makes vaccination less complicated, sooner and utterly painless.
She famous that the vaccine is presently accredited for people aged between 2 and 49, whereas ongoing research intention to increase its use to different age teams sooner or later.
Dr. Ahmed Al Hammadi, Infectious Ailments Marketing consultant and Chairman of the Emirates Infectious Illness Society, mentioned the participation of the affiliation within the convention and the introduction of the brand new vaccine replicate ongoing efforts to boost public consciousness concerning the significance of seasonal influenza vaccination.
He underlined that the initiative seeks to advertise protected and efficient preventive choices, together with fashionable, non-invasive vaccines such because the nasal spray, which supplies each security and comfort. He added that this participation additionally helps nationwide well being methods aimed toward decreasing influenza transmission and defending high-risk populations.
Dr. Eslam El-Baroudy, Professor and Marketing consultant of Paediatrics, and Chief Medical Officer at KidsHeart Centres, described the vaccine’s launch within the area as a significant milestone. He famous that introducing a needle-free possibility can assist overcome kids’s concern of injections and improve parental acceptance of vaccination. He added that scientific research have confirmed the vaccine’s security and effectiveness.
Observe Emirates 24|7 on Google News.